Home Cart 0 Sign in  

[ CAS No. 5733-86-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 5733-86-8
Chemical Structure| 5733-86-8
Structure of 5733-86-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 5733-86-8 ]

Related Doc. of [ 5733-86-8 ]

Alternatived Products of [ 5733-86-8 ]

Product Details of [ 5733-86-8 ]

CAS No. :5733-86-8 MDL No. :MFCD00085749
Formula : C12H13NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :VYKQDWPBYULGPF-UHFFFAOYSA-N
M.W : 219.24 Pubchem ID :99024
Synonyms :

Calculated chemistry of [ 5733-86-8 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.33
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 62.11
TPSA : 57.61 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.64 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.46
Log Po/w (XLOGP3) : -0.01
Log Po/w (WLOGP) : 0.59
Log Po/w (MLOGP) : 1.06
Log Po/w (SILICOS-IT) : 1.28
Consensus Log Po/w : 0.87

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.27
Solubility : 11.7 mg/ml ; 0.0534 mol/l
Class : Very soluble
Log S (Ali) : -0.75
Solubility : 38.9 mg/ml ; 0.178 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.29
Solubility : 1.13 mg/ml ; 0.00516 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.95

Safety of [ 5733-86-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 5733-86-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5733-86-8 ]
  • Downstream synthetic route of [ 5733-86-8 ]

[ 5733-86-8 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 5733-86-8 ]
  • [ 5731-17-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 5, p. 1151 - 1175
  • 2
  • [ 51535-00-3 ]
  • [ 5733-86-8 ]
YieldReaction ConditionsOperation in experiment
97% With lithium hydroxide In tetrahydrofuran; methanol; water for 0.333333 h; Heating / reflux Methyl 1-benzyl-5-oxo-3-pyrrolidinecarboxylate (2.00 g, 8.57 mmol) was dissolved in a mixed solvent of methanol (10 ml) and tetrahydrofuran (10 ml), followed by adding thereto a 2N aqueous lithium hydroxide solution (8.6 ml, 17.2 mmol), and the resulting mixture was heated under reflux for 20 minutes. After completion of the reaction, the reaction solution was ice-cooled, made into an acidic solution with an aqueous potassium hydrogensulfate solution, and then extracted with ethyl acetate. The ethyl acetate layer was concentrated, washed by repulping (ethyl acetate/hexane), and then dried to obtain 1-benzyl-5-oxo-3-pyrrolidinecarboxylic acid (1.83 g, 97percent).1H-NMR (DMSO-d6) δ; 2.56 (2H, m), 3.80 (1H, m), 3.15 (2H, m), 3.25 (2H, m), 4.36 (2H, q, J=8.6Hz), 7.27 (5H, m), 12.61 (1H, s).
Reference: [1] Patent: EP1403255, 2004, A1, . Location in patent: Page 78
[2] Journal of Medicinal Chemistry, 1997, vol. 40, # 15, p. 2374 - 2385
[3] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 1, p. 377 - 379
[4] European Journal of Organic Chemistry, 2005, # 4, p. 673 - 682
[5] Patent: WO2006/123725, 2006, A1, . Location in patent: Page/Page column 64-65
  • 3
  • [ 97-65-4 ]
  • [ 100-46-9 ]
  • [ 5733-86-8 ]
YieldReaction ConditionsOperation in experiment
82.9% at 130℃; for 2.5 h; Inert atmosphere A solution of itaconic acid (18 g, 0.138 mol)And thiamine (14.8 g, 0.138 mol) in a reaction flask,N2 protection,Heated to 130 ° C,Stirring slowly after melting,Reaction 2.5h,Stop heating,When cooled to 100 ° C,200 ml of a 10percent NaOH solution was added under stirring,Cooled to room temperature,The aqueous layer was washed with ethyl acetate,Was added dropwise to the aqueous layer with 10percent hydrochloric acid solution,A large number of white solid generation,To & lt; RTI ID = 0.0 & gt; 1,Washed to a pH of about 6,A white granular solid 25. lg,The yield was 82.9percentMp 143-145 ° C,HRMS = 220.0886 [M + H] & lt; + & gt ;.
Reference: [1] Journal of Organic Chemistry, 2010, vol. 75, # 11, p. 3766 - 3774
[2] Journal of Fluorine Chemistry, 2010, vol. 131, # 2, p. 224 - 228
[3] Patent: CN104447733, 2016, B, . Location in patent: Paragraph 0055; 0056; 0057
[4] Chemical and Pharmaceutical Bulletin, 2004, vol. 52, # 1, p. 63 - 73
[5] Patent: EP1180513, 2002, A1, . Location in patent: Referential example 44
[6] Journal of the American Chemical Society, 1950, vol. 72, p. 1415
[7] Molecules, 2005, vol. 10, # 2, p. 367 - 375
  • 4
  • [ 256451-31-7 ]
  • [ 5733-86-8 ]
Reference: [1] Patent: US6436954, 2002, B1,
  • 5
  • [ 617-52-7 ]
  • [ 5733-86-8 ]
Reference: [1] European Journal of Organic Chemistry, 2005, # 4, p. 673 - 682
[2] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 1, p. 377 - 379
  • 6
  • [ 5733-86-8 ]
  • [ 114214-69-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 5, p. 1151 - 1175
  • 7
  • [ 5733-86-8 ]
  • [ 305329-97-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 5, p. 1151 - 1175
  • 8
  • [ 5733-86-8 ]
  • [ 478832-05-2 ]
Reference: [1] Patent: EP1403255, 2004, A1,
  • 9
  • [ 5733-86-8 ]
  • [ 75-65-0 ]
  • [ 478832-03-0 ]
YieldReaction ConditionsOperation in experiment
51% for 2 h; Heating / reflux In tert-butyl alcohol (6 ml) was dissolved 1-benzyl-5-oxo-3-pyrrolidinecarboxylic acid (1.00 g, 4.56 mmol), and triethylamine (0.76 ml, 5.5 mmol) was added thereto. Then, a solution of diphenylphosphoryl azide (1.38 g, 5.02 mmol) in tert-butyl alcohol (4 ml) was added thereto, and the resulting mixture was refluxed for 2 hours. After completion of the reaction, the reaction solution was concentrated and the tert-butyl alcohol was removed as an azeotrope with toluene as much as possible. The residue was purified by a silica gel chromatography (eluent: ethyl acetate/hexane) to obtain tert-butyl 1-benzyl-5-oxo-3-pyrrolidinylcarbamate (480 mg, 51percent).1H-NMR (DMSO-d6) δ; 1.34 (9H, s), 2.23 (1H, dd, J=5.7, 16.8Hz), 2.61 (1H, dd, J=8.6, 16.8Hz), 3.01 (1H, dd, J=5.7, 9.9Hz), 3.43 (1H, dd, J=8.6, 9.9Hz), 4.03 (1H, m), 4.36 (2H, s), 7.30 (6H, m).
Reference: [1] Patent: EP1403255, 2004, A1, . Location in patent: Page 78-79
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 5733-86-8 ]

Amino Acid Derivatives

Chemical Structure| 1217736-39-4

[ 1217736-39-4 ]

(R)-1-Benzyl-5-oxopyrrolidine-3-carboxylic acid

Similarity: 1.00

Chemical Structure| 351067-50-0

[ 351067-50-0 ]

1-(4-Isopropylbenzyl)-5-oxopyrrolidine-3-carboxylic acid

Similarity: 0.95

Chemical Structure| 96449-93-3

[ 96449-93-3 ]

5-Oxo-1-(1-phenylethyl)pyrrolidine-3-carboxylic acid

Similarity: 0.93

Chemical Structure| 915302-94-2

[ 915302-94-2 ]

(R)-5-Oxo-1-((R)-1-phenylethyl)pyrrolidine-3-carboxylic acid

Similarity: 0.93

Chemical Structure| 479089-86-6

[ 479089-86-6 ]

5-Oxo-1-((S)-1-phenylethyl)pyrrolidine-3-carboxylic acid

Similarity: 0.93